SteelPeak Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
48,151
+21,442
+80% +$1.23M 0.07% 194
2026
Q1
$1.62M Sell
26,709
-9,648
-27% -$562K 0.05% 232
2025
Q4
$1.96M Buy
+36,357
New +$1.75M 0.06% 211
2025
Q3
Sell
-91,354
Closed -$4.23M 595
2025
Q2
$4.23M Sell
91,354
-82,310
-47% -$4.04M 0.16% 109
2025
Q1
$10.6M Sell
173,664
-6,425
-4% -$375K 0.44% 52
2024
Q4
$10.2M Buy
+180,089
New +$10.1M 0.41% 52
2024
Q3
Sell
-99,683
Closed -$4.14M 529
2024
Q2
$4.14M Buy
99,683
+96,572
+3,104% +$4.32M 0.19% 93
2024
Q1
$169K Buy
+3,111
New +$158K 0.01% 436
2023
Q3
Sell
-13,900
Closed -$889K 454
2023
Q2
$889K Buy
13,900
+1,525
+12% +$102K 0.05% 193
2023
Q1
$858K Buy
12,375
+2,748
+29% +$194K 0.06% 175
2022
Q4
$693K Buy
9,627
+290
+3% +$21.9K 0.05% 205
2022
Q3
$664K Sell
9,337
-2,576
-22% -$187K 0.05% 205
2022
Q2
$924K Buy
11,913
+3,947
+50% +$301K 0.07% 178
2022
Q1
$582K Buy
+7,966
New +$535K 0.03% 262
2021
Q2
Sell
-12,906
Closed -$815K 425
2021
Q1
$815K Buy
+12,906
New +$803K 0.06% 180
2020
Q3
Sell
-8,246
Closed -$485K 298
2020
Q2
$485K Buy
8,246
+1,074
+15% +$64.2K 0.06% 165
2020
Q1
$400K Sell
7,172
-28,304
-80% -$1.73M 0.06% 158
2019
Q4
$2.28M Buy
+35,476
New +$2.03M 0.31% 70

Other funds holding BMY

SteelPeak Wealth's BMY Position: Q2 2026 in Review

SteelPeak Wealth increased its Bristol-Myers Squibb (BMY) stake by 80% in Q2 2026, buying an estimated $1.23M and bringing the position to 48,151 shares worth $2.77M. The position accounts for 0.07% of the portfolio, ranked #194.

SteelPeak Wealth first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $10.6M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • SteelPeak Wealth held 48,151 shares of Bristol-Myers Squibb worth $2.77M as of Q2 2026.
  • SteelPeak Wealth bought 21,442 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.23M.
  • Bristol-Myers Squibb made up 0.07% of SteelPeak Wealth's portfolio in Q2 2026, its #194 holding.
  • SteelPeak Wealth first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
  • SteelPeak Wealth's Bristol-Myers Squibb position peaked at $10.6M in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.